Home
>
National Drug Code (NDC)
>
Ranexa
Ranexa - 61958-1004-3 - (ranolazine)
Drug Information of Ranexa
| Product NDC: | 61958-1004 |
| Proprietary Name: | Ranexa |
| Non Proprietary Name: | ranolazine |
| Active Ingredient(s): | 1000 mg/1 & nbsp; ranolazine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ranexa
| Product NDC: | 61958-1004 |
| Labeler Name: | Gilead Sciences, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021526 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070212 |
Package Information of Ranexa
| Package NDC: | 61958-1004-3 |
| Package Description: | 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (61958-1004-3) |
NDC Information of Ranexa
| NDC Code | 61958-1004-3 |
| Proprietary Name | Ranexa |
| Package Description | 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (61958-1004-3) |
| Product NDC | 61958-1004 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ranolazine |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20070212 |
| Marketing Category Name | NDA |
| Labeler Name | Gilead Sciences, Inc. |
| Substance Name | RANOLAZINE |
| Strength Number | 1000 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-anginal [EPC] |
